Trial Profile
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2018
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary) ; Fimasartan/rosuvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 28 Sep 2016 Status changed from not yet recruiting to completed.
- 14 Mar 2016 New trial record